BiomeBank
PrivateLast Round
Strategic
Apr 17, 2026
Est. Valuation
$42.54M
Total Funding Raised
$19.84M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BiomeBank is a biotechnology company that develops microbial therapies to treat and prevent diseases by restoring gut microbial ecology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiomeBank Comparables
Compare BiomeBank with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnteroBiotix | 82% | |
| Human Biome S.A. | 79% | |
| Metagen Therapeutics, Inc. | 79% | |
BiomeBank Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 17, 2026 | ||||
| Grant | Feb 20, 2024 | ||||
| Convertible Debt | Dec 9, 2022 | ||||
| Grant | Apr 27, 2021 | ||||
| Seed | Dec 4, 2018 |
Key People
Founding team and executive leadership
BiomeBank Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovative Manufacturing Cooperative Research Centre | Grant |
| South Australia Government | Convertible Debt |
| The Hospital Research Foundation Group | Convertible Debt, Seed |
| Ellerston Capital | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 133% MoM, reaching 7.4K.
- Apr 17, 2026
$11M round led by Blackmores Limited
BiomeBank Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BiomeBank's valuation, stock price, and market status.